Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin

被引:0
|
作者
Pawel M. Wydorski
Jerzy Osipiuk
Benjamin T. Lanham
Christine Tesar
Michael Endres
Elizabeth Engle
Robert Jedrzejczak
Vishruth Mullapudi
Karolina Michalska
Krzysztof Fidelis
David Fushman
Andrzej Joachimiak
Lukasz A. Joachimiak
机构
[1] University of Texas Southwestern Medical Center,Molecular Biophysics Graduate Program
[2] University of Texas Southwestern Medical Center,Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute
[3] University of Chicago,Center for Structural Biology of Infectious Diseases, Consortium for Advanced Science and Engineering
[4] Argonne National Laboratory,Structural Biology Center, X
[5] University of Maryland,ray Science Division
[6] University of California,Department of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization
[7] University of Chicago,Protein Structure Prediction Center, Genome and Biomedical Sciences Facilities
[8] University of Texas Southwestern Medical Center,Department of Biochemistry and Molecular Biology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with poly-ubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed divergent selectivity for recognition and cleavage of posttranslational conjugates despite sequence conservation. We show that SARS-CoV-2 PLpro binds human ISG15 and K48-linked di-ubiquitin (K48-Ub2) with nanomolar affinity and detect alternate weaker-binding modes. Crystal structures of untethered PLpro complexes with ISG15 and K48-Ub2 combined with solution NMR and cross-linking mass spectrometry revealed how the two domains of ISG15 or K48-Ub2 are differently utilized in interactions with PLpro. Analysis of protein interface energetics predicted differential binding stabilities of the two UBL/Ub domains that were validated experimentally. We emphasize how substrate recognition can be tuned to cleave specifically ISG15 or K48-Ub2 modifications while retaining capacity to cleave mono-Ub conjugates. These results highlight alternative druggable surfaces that would inhibit PLpro function.
引用
收藏
相关论文
共 3 条
  • [1] Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin
    Wydorski, Pawel M. M.
    Osipiuk, Jerzy
    Lanham, Benjamin T. T.
    Tesar, Christine
    Endres, Michael
    Engle, Elizabeth
    Jedrzejczak, Robert
    Mullapudi, Vishruth
    Michalska, Karolina
    Fidelis, Krzysztof
    Fushman, David
    Joachimiak, Andrzej
    Joachimiak, Lukasz A. A.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Crystal structure of the Ube2K/E2-25K and K48-linked di-ubiquitin complex provides structural insight into the mechanism of K48-specific ubiquitin chain synthesis
    Lee, Jung-Gyu
    Youn, Hyung-Seop
    Kang, Jung Youn
    Park, Sam-Yong
    Kidera, Akinori
    Yoo, Yung Joon
    Eom, Soo Hyun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 506 (01) : 102 - 107
  • [3] Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
    Pitsillou, Eleni
    Liang, Julia
    Hung, Andrew
    Karagiannis, Tom C.
    CHEMICAL PHYSICS LETTERS, 2021, 771